-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 0,00 % | -5,94 % | -2,06 % | 88,12 % | 14,46 % | -4,04 % | -60,42 % |
| Northwest Biotherapeutics Inc. | 0,00 % | -8,89 % | -0,61 % | -36,92 % | -20,39 % | -63,72 % | -85,09 % |
| Celldex Therapeutics | -1,67 % | -0,07 % | 3,28 % | 67,46 % | 28,64 % | -14,24 % | 28,87 % |
News
The "Great Rotation" Out of Tech Is Fading. Here Are the Best Artificial Intelligence (AI) Growth Stocks Poised to Benefit.
The so-called "Great Rotation" out of tech and artificial intelligence (AI) stocks appears to have been short-lived. Given that tech and growth stocks have helped power the market higher for much of
3 Artificial Intelligence (AI) Stocks That Are Expected to Grow at Faster Rates Than Nvidia Over the Next Couple of Years, According to Analysts
Tech companies involved in artificial intelligence (AI) have some tremendous growth opportunities ahead that can drive their share prices up far higher in the future. Chipmaker Nvidia (NASDAQ: NVDA)
1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $10,000 and Hold for the Long Term
The artificial intelligence (AI) infrastructure market is booming. The five largest spenders on data center infrastructure are forecast to invest more than $700 billion this year. That is more than


